id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
CPSC-2021-0027-0004,CPSC,CPSC-2021-0027,Poison Prevention Packaging Requirements: Exemption of Baloxavir Marboxil Tablets in Packages Containing Not More than 80 mg of the Drug,Rule,,2024-04-19T04:00:00Z,2024,4,2024-04-19T04:00:00Z,,2024-04-19T15:52:20Z,2024-07651,0,0,09000064864e175e
CPSC-2021-0027-0003,CPSC,CPSC-2021-0027,Phone Log (Schlick-Wilson 3-4-24),Supporting & Related Material,,2024-03-14T04:00:00Z,2024,3,,,2024-03-15T00:37:44Z,,0,0,090000648647b458
CPSC-2021-0027-0001,CPSC,CPSC-2021-0027,Poison Prevention Packaging Requirements: Proposed Exemption of Baloxavir Marboxil Tablets in Packages Containing Not More than 80 mg of the Drug,Proposed Rule,,2021-09-16T04:00:00Z,2021,9,2021-09-16T04:00:00Z,2021-12-01T04:59:59Z,2021-10-16T01:00:51Z,2021-19953,0,0,0900006484d83dab